Matches in Wikidata for { <http://www.wikidata.org/entity/Q38069662> ?p ?o ?g. }
Showing items 1 to 97 of
97
with 100 items per page.
- Q38069662 description "article científic" @default.
- Q38069662 description "article scientifique" @default.
- Q38069662 description "articol științific" @default.
- Q38069662 description "articolo scientifico" @default.
- Q38069662 description "artigo científico" @default.
- Q38069662 description "artigo científico" @default.
- Q38069662 description "artigo científico" @default.
- Q38069662 description "artikel ilmiah" @default.
- Q38069662 description "artikull shkencor" @default.
- Q38069662 description "artículo científico" @default.
- Q38069662 description "artículu científicu espublizáu en 2012" @default.
- Q38069662 description "bilimsel makale" @default.
- Q38069662 description "scienca artikolo" @default.
- Q38069662 description "scientific article published on 19 December 2012" @default.
- Q38069662 description "scientific article published on 19 December 2012" @default.
- Q38069662 description "scientific article published on 19 December 2012" @default.
- Q38069662 description "vedecký článok" @default.
- Q38069662 description "vetenskaplig artikel" @default.
- Q38069662 description "videnskabelig artikel" @default.
- Q38069662 description "vitenskapelig artikkel" @default.
- Q38069662 description "vitskapeleg artikkel" @default.
- Q38069662 description "vědecký článek" @default.
- Q38069662 description "wetenschappelijk artikel" @default.
- Q38069662 description "wissenschaftlicher Artikel" @default.
- Q38069662 description "наукова стаття, опублікована в грудні 2012" @default.
- Q38069662 description "научная статья" @default.
- Q38069662 description "научни чланак" @default.
- Q38069662 description "מאמר מדעי" @default.
- Q38069662 description "مقالة علمية نشرت في 19 ديسمبر 2012" @default.
- Q38069662 description "বৈজ্ঞানিক নিবন্ধ" @default.
- Q38069662 name "Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: rationale for future randomised trials in human papilloma virus-negative disease." @default.
- Q38069662 name "Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: rationale for future randomised trials in human papilloma virus-negative disease." @default.
- Q38069662 type Item @default.
- Q38069662 label "Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: rationale for future randomised trials in human papilloma virus-negative disease." @default.
- Q38069662 label "Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: rationale for future randomised trials in human papilloma virus-negative disease." @default.
- Q38069662 prefLabel "Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: rationale for future randomised trials in human papilloma virus-negative disease." @default.
- Q38069662 prefLabel "Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: rationale for future randomised trials in human papilloma virus-negative disease." @default.
- Q38069662 P1433 Q38069662-0C809AB7-52EE-4C42-B7F1-3EABC5988001 @default.
- Q38069662 P1476 Q38069662-1532992F-B5EB-440A-84FB-ED0548E56EDE @default.
- Q38069662 P2093 Q38069662-234E7C02-3A54-4F42-8B5F-2AC1FD3C4DEF @default.
- Q38069662 P2093 Q38069662-2D6838C3-4956-44AC-9AC8-AC069E2B60BE @default.
- Q38069662 P2093 Q38069662-333A7B10-D279-4DF5-91C5-A5658A396D5D @default.
- Q38069662 P2093 Q38069662-39C1C50B-26F8-422D-A818-DA714BF9D9F9 @default.
- Q38069662 P2093 Q38069662-3B20F874-51C7-499B-A4E0-AEF277EDA270 @default.
- Q38069662 P2093 Q38069662-3D97D111-43B2-4177-B72C-CEE474531E16 @default.
- Q38069662 P2093 Q38069662-733D8A8B-AEEC-4482-A1C9-952B78EA79E5 @default.
- Q38069662 P2093 Q38069662-799E0EF0-D4B2-47EF-9B8E-E14C19ECB2A5 @default.
- Q38069662 P2093 Q38069662-89D85993-5BAA-403B-81AB-37D6E5BBCA98 @default.
- Q38069662 P2093 Q38069662-8EC10343-9755-4942-8151-409032382594 @default.
- Q38069662 P2093 Q38069662-9547E107-38C4-410F-85DE-AB301076A0D2 @default.
- Q38069662 P2093 Q38069662-C28EB07F-C06B-4B25-951F-C5493561C2C1 @default.
- Q38069662 P2093 Q38069662-D0EAB400-71FA-4833-8E8B-0DCCDE0CF404 @default.
- Q38069662 P2093 Q38069662-EF198895-11AA-4E99-81C8-7F0F8C282591 @default.
- Q38069662 P304 Q38069662-A1F29916-0E21-47F2-A74B-653B51BAA83A @default.
- Q38069662 P31 Q38069662-E2B8D5CC-B792-4F71-9E22-F93D8BFB7A46 @default.
- Q38069662 P356 Q38069662-3F9DAD38-7E43-429F-90E5-60B938943076 @default.
- Q38069662 P407 Q38069662-40354CBA-0781-4EF4-BB6D-B5C1CFDEF769 @default.
- Q38069662 P433 Q38069662-C1275C95-2500-4462-9EA8-BB6DA8E13B57 @default.
- Q38069662 P478 Q38069662-0AC83EE9-0B17-4807-B417-D8B608874D1C @default.
- Q38069662 P50 Q38069662-5A900E7E-7EA4-41B0-A62D-B0827EA1DE1D @default.
- Q38069662 P577 Q38069662-CB99FF38-F713-48BE-9503-CD8D274FB658 @default.
- Q38069662 P698 Q38069662-260D3E74-252F-4C74-8C2F-3CDD4324BEBF @default.
- Q38069662 P921 Q38069662-2F52EF70-B351-4A3A-BF8E-9A3C6F44D4CF @default.
- Q38069662 P921 Q38069662-31987FAC-86AB-4C75-AD88-03D68A8B7787 @default.
- Q38069662 P921 Q38069662-F624E5C2-B0D2-498B-928D-A357F993D531 @default.
- Q38069662 P921 Q38069662-F6BD9AF0-16C5-4D50-8D9B-5DB93F259466 @default.
- Q38069662 P356 J.EJCA.2012.11.023 @default.
- Q38069662 P698 23265705 @default.
- Q38069662 P1433 Q332260 @default.
- Q38069662 P1476 "Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: rationale for future randomised trials in human papilloma virus-negative disease" @default.
- Q38069662 P2093 "Alain Berrier" @default.
- Q38069662 P2093 "Eva Remenar" @default.
- Q38069662 P2093 "Fernando Hurtado de Mendoza" @default.
- Q38069662 P2093 "Iman El-Hariry" @default.
- Q38069662 P2093 "Jérôme Fayette" @default.
- Q38069662 P2093 "Kevin Harrington" @default.
- Q38069662 P2093 "Martin Housset" @default.
- Q38069662 P2093 "Martin Robinson" @default.
- Q38069662 P2093 "Mike Lau" @default.
- Q38069662 P2093 "Natalie Compton" @default.
- Q38069662 P2093 "Natalie Franklin" @default.
- Q38069662 P2093 "Nigel Biswas-Baldwin" @default.
- Q38069662 P2093 "Philippe Legenne" @default.
- Q38069662 P2093 "Rejnish Kumar" @default.
- Q38069662 P304 "1609-1618" @default.
- Q38069662 P31 Q13442814 @default.
- Q38069662 P356 "10.1016/J.EJCA.2012.11.023" @default.
- Q38069662 P407 Q1860 @default.
- Q38069662 P433 "7" @default.
- Q38069662 P478 "49" @default.
- Q38069662 P50 Q56450550 @default.
- Q38069662 P577 "2012-12-19T00:00:00Z" @default.
- Q38069662 P698 "23265705" @default.
- Q38069662 P921 Q18348812 @default.
- Q38069662 P921 Q42824440 @default.
- Q38069662 P921 Q5090613 @default.
- Q38069662 P921 Q69999790 @default.